The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germ-line biomarkers disrupting microRNA regulatory pathways to predict toxicity and response to anti-PD-1 and anti-PD-L1 therapies.
 
Joanne B. Weidhaas
Stock and Other Ownership Interests - Mira Dx; Mira Dx (I)
Patents, Royalties, Other Intellectual Property - Mira Dx
 
Donatello Telesca
No Relationships to Disclose
 
Anusha Kalbasi
No Relationships to Disclose
 
David Salzman
Employment - Mira Dx
Stock and Other Ownership Interests - Mira Dx
 
Antoni Ribas
Stock and Other Ownership Interests - Arcus Ventures; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis